Pilot Study of partially Human Leucocyte Antigen (HLA)-mismatched stem cell infusions after chemotherapy for acute myeloid leukaemia in patients over the age of 60.

Phase 1

• Conditions: Acute Myeloid Leukaemia > 60 yrs; Blood - Haematological diseases; Cancer - Leukaemia - Acute leukaemia

• Registration Number: ACTRN12613000337774
• Lead Sponsor: St Vincent's Hospital, Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Patients aged over 60 with previously untreated AML undergoing induction chemotherapy, who have an available partially HLA-mismatched donor

Exclusion Criteria

Patient with Acute Promyelocytic Leukaemia, Chronic Myeloid Leukaemia or unfit for induction chemotherapy or have immunodeficiency (apart from neutropenia)

Study & Design

• Study Type: Interventional
• Study Design: Not specified